DCF Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
DCF Advisers's AMGN Position: Q3 2026 in Review
DCF Advisers reduced its Amgen (AMGN) stake by 38% in Q3 2026, selling an estimated $797K and leaving 3,250 shares worth $1.37M. The position accounts for 0.31% of the portfolio, ranked #61.
DCF Advisers first reported a position in AMGN in Q4 2019 and has held it in 24 quarters since. The position peaked at $4.42M in Q4 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- DCF Advisers held 3,250 shares of Amgen worth $1.37M as of Q3 2026.
- DCF Advisers sold 2,000 Amgen shares in Q3 2026, an estimated $797K.
- Amgen made up 0.31% of DCF Advisers's portfolio in Q3 2026, its #61 holding.
- DCF Advisers first reported a position in Amgen in Q4 2019 and has held it in 24 quarters since.
- DCF Advisers's Amgen position peaked at $4.42M in Q4 2025.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.